Tejnaksh Healthcare Limited carries a market capitalization of 288.86M, placing it among publicly traded companies globally. Its enterprise value stands at 234.66M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 288.86M |
| Enterprise Value | 234.66M |
Tejnaksh Healthcare Limited currently has 20.31M shares outstanding.
| Shares Outstanding | 20.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Tejnaksh Healthcare Limited trades at a trailing price-to-earnings ratio of 20.21. The price-to-sales ratio is 2.30, and the price-to-book ratio stands at 2.44.
| PE Ratio | 20.21 |
| PS Ratio | 2.30 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 1.02 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Tejnaksh Healthcare Limited trades at an EV/EBITDA multiple of 17.40 and an EV/FCF ratio of 261.87. The EV/Sales ratio of 2.18 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.40 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.18 |
| EV / EBITDA | 17.40 |
| EV / EBIT | 17.40 |
| EV / FCF | 261.87 |
Tejnaksh Healthcare Limited maintains a current ratio of 8.45, meaning it holds 8.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.89, indicating moderate leverage, while an interest coverage ratio of 10.80 demonstrates strong ability to service its debt obligations.
| Current Ratio | 8.45 |
| Quick Ratio | 3.33 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 0.18 |
| Interest Coverage | 10.80 |
Tejnaksh Healthcare Limited posts a return on equity of 7.26 and a return on invested capital of 3.49.
| Return on Equity (ROE) | 7.26 |
| Return on Assets (ROA) | 4.07 |
| Return on Invested Capital (ROIC) | 3.49 |
| Return on Capital Employed (ROCE) | 7.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.26 |
Over the trailing twelve months, Tejnaksh Healthcare Limited has paid 4.65M in income taxes, reflecting an effective tax rate of 28.25.
| Income Tax | 4.65M |
| Effective Tax Rate | 28.25 |
Tejnaksh Healthcare Limited's stock has declined approximately -27.18894% over the past 52 weeks. The 50-day moving average sits at 15.01, while the 200-day moving average is 15.33.
| Beta (5Y) | N/A |
| 52-Week Price Change | -27.18894% |
| 50-Day Moving Average | 15.01 |
| 200-Day Moving Average | 15.33 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Tejnaksh Healthcare Limited generated 107.87M in revenue and converted that into 12.28M in net income, yielding earnings per share of 0.57. EBITDA reached 13.49M, while operating income came in at 13.49M.
| Revenue | 107.87M |
| Gross Profit | 97.69M |
| Operating Income | 13.49M |
| Pretax Income | 16.46M |
| Net Income | 12.28M |
| EBITDA | 13.49M |
| EBIT | 13.49M |
| Earnings Per Share (EPS) | 0.57 |
Tejnaksh Healthcare Limited holds 20.93M in cash and equivalents against 2.46M in total debt, resulting in a net debt position of -19.50M. Total book value stands at 101.57M, with working capital of 46.77M providing operational flexibility.
| Cash & Cash Equivalents | 20.93M |
| Total Debt | 2.46M |
| Net Debt | -19.50M |
| Equity (Book Value) | 101.57M |
| Book Value Per Share | 4.88 |
| Working Capital | 46.77M |
Tejnaksh Healthcare Limited operates with a gross margin of 90.56, reflecting its pricing power and cost economics. The operating margin of 12.50 and net profit margin of 11.39 provide insight into operational efficiency.
| Gross Margin | 90.56 |
| Operating Margin | 12.50 |
| Pretax Margin | 15.26 |
| Profit Margin | 11.39 |
| EBITDA Margin | 12.50 |
Tejnaksh Healthcare Limited's most recent stock split took place on July 19, 2023 with a 1:2 split ratio.
| Last Split Date | 7/19/2023 |
| Split Ratio | 1:2 |
Tejnaksh Healthcare Limited posts an Altman Z-Score of 6.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.97 |